Evidence map›Paper›PMID 33066265›Full record

ArticlePolymers2020

A Versatile Open-Source Printhead for Low-Cost 3D Microextrusion-Based Bioprinting.

Andres Sanz-Garcia, Enrique Sodupe-Ortega, Alpha Pernía-Espinoza, Tatsuya Shimizu, Carmen Escobedo-Lucea

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Extrusion bioprinting: meeting the promise of human tissue biofabrication?Progress in biomedical engineering (Bristol, England) · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Andres Sanz-GarciaDivision of Pharmaceutical Biosciences. University of Helsinki. Viikinkaari 5 E (P.O. Box 56), 00014 Helsinki, Finland.
Enrique Sodupe-OrtegaDivision of Pharmaceutical Biosciences. University of Helsinki. Viikinkaari 5 E (P.O. Box 56), 00014 Helsinki, Finland.
Alpha Pernía-EspinozaDepartment of Mechanical Engineering, University of La Rioja. San José de Calasanz 31, Edificio Departamental, 26004 Logroño, Spain.
Tatsuya ShimizuInstitute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Carmen Escobedo-LuceaDivision of Pharmaceutical Biosciences. University of Helsinki. Viikinkaari 5 E (P.O. Box 56), 00014 Helsinki, Finland.
University of Helsinki · FITokyo Women's Medical University · JPUniversidad de La Rioja · ES

Funding

Academy of Finland 266486Academy of Finland 273689Academy of Finland 276371Academy of Finland 286793
6 · The paper itself

Abstract

Three-dimensional (3D) bioprinting promises to be essential in tissue engineering for solving the rising demand for organs and tissues. Some bioprinters are commercially available, but their impact on the field of Tissue engineering (TE) is still limited due to their cost or difficulty to tune. Herein, we present a low-cost easy-to-build printhead for microextrusion-based bioprinting (MEBB) that can be installed in many desktop 3D printers to transform them into 3D bioprinters. We can extrude bioinks with precise control of print temperature between 2-60 °C. We validated the versatility of the printhead, by assembling it in three low-cost open-source desktop 3D printers. Multiple units of the printhead can also be easily put together in a single printer carriage for building a multi-material 3D bioprinter. Print resolution was evaluated by creating representative calibration models at different temperatures using natural hydrogels such as gelatin and alginate, and synthetic ones like poloxamer. Using one of the three modified low-cost 3D printers, we successfully printed cell-laden lattice constructs with cell viabilities higher than 90% after 24-h post printing. Controlling temperature and pressure according to the rheological properties of the bioinks was essential in achieving optimal printability and great cell viability. The cost per unit of our device, which can be used with syringes of different volume, is less expensive than any other commercially available product. These data demonstrate an affordable open-source printhead with the potential to become a reliable alternative to commercial bioprinters for any laboratory.

Indexed as

bioinkbioprintingmicroextrusionopen-sourcestem cellstissue engineering

Identifiers

PMID33066265
PMCPMC7602012
OpenAlexW3092296670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.